Management of rhesus alloimmunization in pregnancy

Obstetrics and Gynecology

Volumn 112, Issue 1, 2008, Pages 164-176

  Moise Jr , Kenneth J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ERYTHROPOIETIN; MATERNAL ANTIBODY; RHESUS D ANTIBODY; RHESUS D ANTIGEN; IMMUNOLOGIC FACTOR;

AMNIOCENTESIS; ANEMIA; ANTIBODY TITER; BLOOD GROUP TYPING; CLINICAL TRIAL; CONSULTATION; DIAGNOSTIC PROCEDURE; DOPPLER FLOWMETRY; ERYTHROCYTE; ERYTHROPOIESIS; FETUS BLOOD; FETUS BLOOD SAMPLING; FETUS HYDROPS; GENETICS; GENOTYPE; HIGH RISK PREGNANCY; HUMAN; IMMUNE SYSTEM; INTRAUTERINE BLOOD TRANSFUSION; MATERNAL PLASMA; MIDDLE CEREBRAL ARTERY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PATIENT REFERRAL; PLASMAPHERESIS; PREGNANCY; PRENATAL CARE; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RHESUS ISOIMMUNIZATION; RISK ASSESSMENT; SURVIVAL RATE; UMBILICAL CORD; BLOOD FLOW VELOCITY; BLOOD GROUP RHESUS SYSTEM; ECHOGRAPHY; FEMALE; IMMUNOLOGY; METHODOLOGY; NEWBORN HEMOLYTIC DISEASE;

BLOOD FLOW VELOCITY; BLOOD TRANSFUSION, INTRAUTERINE; ERYTHROBLASTOSIS, FETAL; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MIDDLE CEREBRAL ARTERY; PREGNANCY; RH ISOIMMUNIZATION; RH-HR BLOOD-GROUP SYSTEM; RHO(D) IMMUNE GLOBULIN;

EID: 48549093650     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31817d453c     Document Type: Review

References (46)

1. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Munson ML. Births: Final data for 2003. Natl Vital Stat Rep 2005;54:1-116.
2. BowmanJM, PollockJM, Penston LE. Fetomaternal transplacental hemorrhage during pregnancy and after delivery. Vox Sang 1986;51:117-21.
3. Siberil S, de Romeuf C, Bihoreau N, Fernandez N, Meterreau JL, Regenman A, et al. Selection of a human anti-RhD monoclonal antibody for therapeutic use: impact of IgG glycosylation on activating and inhibitory Fc gamma R functions. Clin Immunol 2006;118:170-9.
4. Bowman JM. The prevention of Rh immunization. Transfus Med Rev 1988;2:129-50.
5. Prevention of RhD alloimmunization. ACOG Practice Bulletin No. 4. American College of Obstetricians and Gynecologists. Obstet Gynecol 1999.
6. BowmanJM. Controversies in Rh prophylaxis. Who needs Rh immune globulin and when should it be given? Am J Obstet Gynecol 1985;151:289-94.
7. Hughes RG, Craig JI, Murphy WG, Greer IA. Causes and clinical consequences of Rhesus (D) haemolytic disease of the newborn: a study of a Scottish population, 1985-1990. Br J Obstet Gynaecol 1994;101:297-300.
8. Cherif-Zahar B, Mattei MG, Le Van Kim C, Bailly P, Cartron JP, Colin Y. Localization of the human Rh blood group gene structure to chromosome region Ip34.3-lp36.1 by in situ hybridization. Hum Genet 1991;86:398-400.
9. Carritt B, Kemp TJ, Poulter M. Evolution of the human RH (rhesus) blood group genes: a 50 year old prediction (partially) fulfilled [published erratum appears in Hum Mol Genet 1997; 6:1390]. Hum Mol Genet 1997;6:843-50.
10. Avent ND. Fetal genotyping. In: Hadley A, Soothill P, editors. Alloimmune disorders in pregnancy anaemia, thrombocytopenia, and neutropenia in the fetus and newborn. Cambridge (UK): Cambridge University Press; 2002.
11. Pirelli K, Pietz B, Johnson S, Pinder H, Bellissimo D. Molecular determination of RhD zygosity. Am J Obstet Gynecol 2006;195:S172.
12. Moise KJ, Carpenter RJ. Increased severity of fetal hemolytic disease with known rhesus alloimmunization after first-trimester transcervical chorionic villus biopsy. Fetal Diagn Ther 1990;5:76-8.
13. Van den Veyver IB, Moise KJ. Fetal RhD typing by polymerase chain reaction in pregnancies complicated by rhesus alloimmunization. Obstet Gynecol 1996;88:1061-7.
14. Singleton BK, Green CA, Avent ND, Martin PG, Smart E, Daka A, et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood 2000; 95:12-8.
15. Lo YM, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998; 339:1734-8.
16. Geifman-Holtzman O, Grotegut CA, GaughanJP. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood-a meta-analysis. Am J Obstet Gynecol 2006;195:1163-73.
17. Brown S, Kellner LH, Munson M, Munson M, Yang Y, Klotzle B, et al. Non-invasive prenatal testing: technical strategies to achieve testing of cell free fetal DNA (CFFDNA) RhD genotype in a clinical lab. Am J Obstet Gynecol 2007;197:S173.
18. Nicolaides KH, Rodeck CH. Maternal serum anti-D antibody concentration and assessment of rhesus isoimmunisation. BMJ 1992;304:1155-6.
19. Soothill PW, Nicolaides KH, Rodeck CH, Clewell WH, Lindridge J. Relationship of fetal hemoglobin and oxygen content to lactate concentration in Rh isoimmunized pregnancies. Obstet Gynecol 1987;69:268-71.
20. Mari G, Deter RL, Carpenter RL, Rahman F, Zimmerman R, Moise KJ Jr, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med 2000;342: 9-14.
21. Divakaran TG, Waugh J, Clark TJ, Khan KS, Whittle MJ, Kilby MD. Noninvasive techniques to detect fetal anemia due to red blood cell alloimmunization: a systematic review. Obstet Gynecol 2001;98:509-17.
22. Oepkes D, Seaward PG, Vandenbussche FP, Windrim R, Kingdom J, Beyene J, et al. Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med 2006;355: 156-64.
23. Abel DE, Grambow SC, Brancazio LR, Hertzberg BS. Ultrasound assessment of the fetal middle cerebral artery peak systolic velocity: A comparison of the near-field versus far-field vessel. Am J Obstet Gynecol 2003;189:986-9.
24. Sallout BI, Fung KF, Wen SW, Medd LM, Walker MC. The effect of fetal behavioral states on middle cerebral artery peak systolic velocity. Am J Obstet Gynecol 2004;191:1283-7.
25. Zimmerman R, Carpenter RJ, Durig P, Mari G Longitudinal measurement of peak systolic velocity in the fetal middle cerebral artery for monitoring pregnancies complicated by red cell alloimmunisation: a prospective multicentre trial with intention-to-treat. BJOG 2002;109:746-52.
26. Mari G Middle cerebral artery peak systolic velocity: is it the standard of care for the diagnosis of fetal anemia? J Ultrasound Med 2005;24:697-702.
27. Trevett TN, Dorman K, Lamvu G, Moise KJ. Antenatal maternal administration of phenobarbital for the prevention of exchange transfusion in neonates with hemolytic disease of the fetus and newborn. Am J Obstet Gynecol 2005;192:478-82.
28. Liley AW. Intrauterine transfusion of foetus in haemolytic disease. Br Med J 1963;2:1107-9.
29. Giannina G, Moise KJ, Dorman K A simple method to estimate the volume for fetal intravascular transfusion. Fetal Diagn Ther 1998;13:94-7.
30. Radunovic N, Lockwood CJ, Alvarez M, Plecas D, Chitkara U, Berkowitz RL. The severely anemic and hydropic isoimmune fetus: changes in fetal hematocrit associated with intrauterine death. Obstet Gynecol 1992;79:390-3.
31. van Kamp IL, Klumper FJ, Bakkum RS, Oepkes D, Meerman RH, Scherjon SA, et al. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment. Am J Obstet Gynecol 2001;185:668-73.
32. Detti L, Oz U, Guney I, Ferguson JE, Bahado-Singh RO, Mari G, et al. Doppler ultrasound velocimetry for timing the second intrauterine transfusion in fetuses with anemia from red cell alloimmunization. Am J Obstet Gynecol 2001;185:1048-51.
33. Scheier M, Hernandez-Andrade E, Carmo A, Dezerega V, Nicolaides KH. Prediction of fetal anemia in rhesus disease by measurement of fetal middle cerebral artery peak systolic velocity. Ultrasound Obstet Gynecol 2004;23:432-6.
34. Klumper FJ, van Kamp IL, Vandenbussche FP, Meerman RH, Oepkes D, Scherjon SA, et al. Benefits and risks of fetal red-cell transfusion after 32 weeks gestation. Eur J Obstet Gynecol Reprod Biol 2000;92:91-6.
35. Howe DT, Michailidis GD. Intraperitoneal transfusion in severe, early-onset Rh isoimmunization. Obstet Gynecol 2007;110: 880-4.
36. Ruma MS, Moise KJ, Kim E, Murtha AP, Prutsman WJ, Hassan SS, et al. Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization. Am J Obstet Gynecol 2007;196:138.e1-6.
37. van Kamp IL, Klumper FJ, Oepkes D, Meerman RH, Scherjon SA, Vandenbussche FP, et al. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. Am J Obstet Gynecol 2005;192:171-7.
38. Saade GR, Moise KJ, Belfort MA, Hesketh DE, Carpenter RJ. Fetal and neonatal hematologic parameters in red cell alloimmunization: predicting the need for late neonatal transfusions. Fetal Diagn Ther 1993;8:161-4.
39. De Boer I P, Zeestraten E C, Lopriore E, van Kamp IL, Kanhai HH, Walther FJ. Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion. Am J Obstet Gynecol 2008; 198:54 e1-4.
40. Ovali F, Samanci N, Dagoglu T. Management of late anemia in Rhesus hemolytic disease: use of recombinant human erythropoietin (a pilot study). Pediatr Res 1996;39:831-4.
41. Hudon L, Moise KJ Hegemier SE, Hill RM, Moise AA, Smith EO, et al. Long-term neurodevelopmental outcome after intrauterine transfusion for the treatment of fetal hemolytic disease. Am J Obstet Gynecol 1998;179:858-63.
42. Harper DC, Swingle HM, Weiner CP, Bonthius DJ, Aylward GP, Widness JA. Long-term neurodevelopmental outcome and brain volume after treatment for hydrops fetalis by in utero intravascular transfusion. Am J Obstet Gynecol 2006;195:192-200.
43. Moise KJ, Whitecar PW. Antenatal therapy for haemolytic disease of the fetus and newborn. In: Hadley A, Soothill P, editors. Alloimmune disorders in pregnancy anaemia, thrombocytopenia and neutropenia in the fetus and newborn. Cambridge (UK): Cambridge University Press; 2002.
44. Whitecar PW, Farb R, Subramanyam L, Dorman K, Balu RB, Moise KJ. Paternal leukocyte alloimmunization as a treatment for hemolytic disease of the newborn in a rabbit model. Am J Obstet Gynecol 2002;187:977-80.
45. Hall AM, Cairns LS, Altmann DM, Barker RN, Urbaniak SJ. Immune responses and tolerance to the RhD blood group protein in HLA-transgenic mice. Blood 2005;105:2175-9.
46. Schumacher B, Moise KJ. Fetal transfusion for red blood cell alloimmunization in pregnancy. Obstet Gynecol 1996;88: 137-50.